Revvity Common Stock Net 2010-2025 | RVTY
Revvity common stock net from 2010 to 2025. Common stock net can be defined as the value of common equity ownership.
- Revvity common stock net for the quarter ending June 30, 2025 was $0.116B, a 5.7% decline year-over-year.
- Revvity common stock net for 2024 was $0.121B, a 2.25% decline from 2023.
- Revvity common stock net for 2023 was $0.123B, a 2.28% decline from 2022.
- Revvity common stock net for 2022 was $0.126B, a 0.05% increase from 2021.
| Revvity Annual Common Stock Net (Millions of US $) |
|
|---|---|
| 2024 | $121 |
| 2023 | $123 |
| 2022 | $126 |
| 2021 | $126 |
| 2020 | $112 |
| 2019 | $111 |
| 2018 | $111 |
| 2017 | $110 |
| 2016 | $110 |
| 2015 | $112 |
| 2014 | $112 |
| 2013 | $113 |
| 2012 | $115 |
| 2011 | $113 |
| 2010 | $116 |
| 2009 | $117 |
| Revvity Quarterly Common Stock Net (Millions of US $) |
|
|---|---|
| 2025-06-30 | $116 |
| 2025-03-31 | $119 |
| 2024-12-31 | $121 |
| 2024-09-30 | $122 |
| 2024-06-30 | $123 |
| 2024-03-31 | $123 |
| 2023-12-31 | $123 |
| 2023-09-30 | $123 |
| 2023-06-30 | $124 |
| 2023-03-31 | $126 |
| 2022-12-31 | $126 |
| 2022-09-30 | $126 |
| 2022-06-30 | $126 |
| 2022-03-31 | $126 |
| 2021-12-31 | $126 |
| 2021-09-30 | $126 |
| 2021-06-30 | $112 |
| 2021-03-31 | $112 |
| 2020-12-31 | $112 |
| 2020-09-30 | $112 |
| 2020-06-30 | $112 |
| 2020-03-31 | $111 |
| 2019-12-31 | $111 |
| 2019-09-30 | $111 |
| 2019-06-30 | $111 |
| 2019-03-31 | $111 |
| 2018-12-31 | $111 |
| 2018-09-30 | $111 |
| 2018-06-30 | $111 |
| 2018-03-31 | $111 |
| 2017-12-31 | $110 |
| 2017-09-30 | $110 |
| 2017-06-30 | $110 |
| 2017-03-31 | $110 |
| 2016-12-31 | $110 |
| 2016-09-30 | $110 |
| 2016-06-30 | $109 |
| 2016-03-31 | $109 |
| 2015-12-31 | $112 |
| 2015-09-30 | $112 |
| 2015-06-30 | $113 |
| 2015-03-31 | $113 |
| 2014-12-31 | $112 |
| 2014-09-30 | $113 |
| 2014-06-30 | $113 |
| 2014-03-31 | $113 |
| 2013-12-31 | $113 |
| 2013-09-30 | $112 |
| 2013-06-30 | $112 |
| 2013-03-31 | $112 |
| 2012-12-31 | $115 |
| 2012-09-30 | $115 |
| 2012-06-30 | $114 |
| 2012-03-31 | $114 |
| 2011-12-31 | $113 |
| 2011-09-30 | $113 |
| 2011-06-30 | $113 |
| 2011-03-31 | $113 |
| 2010-12-31 | $116 |
| 2010-09-30 | $118 |
| 2010-06-30 | $118 |
| 2010-03-31 | $118 |
| 2009-12-31 | $117 |
| 2009-09-30 | $117 |
| 2009-06-30 | $117 |
| 2009-03-31 | $116 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.554B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $149.755B | 27.77 |
| CVS Health (CVS) | United States | $83.583B | 10.39 |
| Elevance Health (ELV) | United States | $66.299B | 8.92 |
| Cencora (COR) | United States | $56.410B | 18.79 |
| DiDi Global (DIDIY) | China | $26.262B | 27.90 |
| Labcorp Holdings (LH) | United States | $22.648B | 18.00 |
| Natera (NTRA) | United States | $21.644B | 0.00 |
| BioMerieux (BMXMF) | France | $17.238B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.857B | 0.00 |
| ICON (ICLR) | Ireland | $14.237B | 13.70 |
| CochLear (CHEOY) | Australia | $13.302B | 0.00 |
| Medpace Holdings (MEDP) | United States | $13.148B | 34.80 |
| Solventum (SOLV) | United States | $12.897B | 13.31 |
| Viatris (VTRS) | United States | $12.137B | 4.32 |
| Caris Life Sciences,�Inc (CAI) | United States | $9.640B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $9.130B | 0.00 |
| Avantor (AVTR) | United States | $8.910B | 13.07 |
| HealthEquity (HQY) | United States | $7.720B | 33.81 |
| Charles River Laboratories (CRL) | United States | $7.628B | 14.47 |
| Bausch + Lomb (BLCO) | Canada | $5.016B | 33.74 |
| Sotera Health (SHC) | United States | $4.465B | 24.95 |
| BrightSpring Health Services (BTSG) | United States | $3.966B | 30.26 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.536B | 80.99 |
| Surgery Partners (SGRY) | United States | $3.021B | 38.00 |
| Concentras Parent (CON) | United States | $2.930B | 18.58 |
| Alignment Healthcare (ALHC) | United States | $2.923B | 0.00 |
| Organon (OGN) | United States | $2.433B | 2.65 |
| Premier (PINC) | United States | $2.020B | 15.33 |
| Progyny (PGNY) | United States | $1.983B | 41.93 |
| Ardent Health (ARDT) | United States | $1.813B | 7.00 |
| PACS (PACS) | United States | $1.750B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.350B | 9.01 |
| Teladoc Health (TDOC) | United States | $1.315B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.272B | 20.94 |
| Establishment Labs Holdings (ESTA) | $1.111B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.965B | 0.00 |
| Embecta (EMBC) | United States | $0.815B | 4.77 |
| AMN Healthcare Services Inc (AMN) | United States | $0.714B | 8.83 |
| CareDx (CDNA) | United States | $0.646B | 11.89 |
| Performant Healthcare (PHLT) | United States | $0.601B | 0.00 |
| Nutex Health (NUTX) | United States | $0.584B | 8.85 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 200.00 |
| So-Young (SY) | China | $0.517B | 0.00 |
| Omada Health (OMDA) | $0.517B | 0.00 | |
| InnovAge Holding (INNV) | United States | $0.494B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.489B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 10.50 |
| SBC Medicals (SBC) | United States | $0.447B | 9.81 |
| Agilon Health (AGL) | United States | $0.435B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.412B | 0.00 |
| Enhabit (EHAB) | United States | $0.384B | 25.23 |
| Oncology Institute (TOI) | United States | $0.366B | 0.00 |
| LifeMD (LFMD) | United States | $0.327B | 0.00 |
| Beauty Health (SKIN) | United States | $0.300B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.200B | 0.00 |
| DocGo (DCGO) | United States | $0.176B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.132B | 0.00 |
| KindlyMD (NAKA) | United States | $0.101B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.087B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.056B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.049B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.043B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.039B | 0.00 |
| ModivCare (MODV) | United States | $0.032B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |